Prismatic Lenses and tDCS in Neglect

Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Apr 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new rehabilitation method for people who have experienced a stroke, specifically targeting those with a condition called spatial heminegligence. This condition can make it difficult for patients to notice or pay attention to one side of their environment after a right-sided stroke. The researchers want to see if using special prismatic lenses, combined with a treatment called transcranial direct current stimulation (tDCS), can help improve attention and reduce neglect compared to just using prismatic lenses with a placebo treatment (which looks like the real treatment but doesn’t have any effect).

To participate in this study, individuals must be over 18 years old, have had an ischemic stroke (which happens when a blood vessel supplying blood to the brain is blocked), and must have been hospitalized within the last 90 days. Unfortunately, those who have had a hemorrhagic stroke (where there is bleeding in the brain), have a history of other neurological or psychiatric diseases, or use alcohol and drugs cannot join. If eligible, participants can expect to receive treatment and support to help improve their recovery, and their progress will be closely monitored throughout the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age \>18 years
• • ischemic stroke
• • hospitalization within 90 days of the event
• Exclusion Criteria:
• • heamorrhagic stroke
• • history of neurological disease
• • history of psychiatric disease
• • use of alchool and drugs